-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Axsome Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2021 to Q3 2024.
- Axsome Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $167M, a 39.6% increase year-over-year.
- Axsome Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $645M, a 54.6% increase year-over-year.
- Axsome Therapeutics, Inc. annual Costs and Expenses for 2023 was $502M, a 119% increase from 2022.
- Axsome Therapeutics, Inc. annual Costs and Expenses for 2022 was $230M, a 84.3% increase from 2021.
- Axsome Therapeutics, Inc. annual Costs and Expenses for 2021 was $125M, a 25.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)